FI970328A - Heterosykliset yhdisteet, jotka ovat käyttökelpoisia allosteerisinä effektoreina muskariinireseptoreissa - Google Patents
Heterosykliset yhdisteet, jotka ovat käyttökelpoisia allosteerisinä effektoreina muskariinireseptoreissa Download PDFInfo
- Publication number
- FI970328A FI970328A FI970328A FI970328A FI970328A FI 970328 A FI970328 A FI 970328A FI 970328 A FI970328 A FI 970328A FI 970328 A FI970328 A FI 970328A FI 970328 A FI970328 A FI 970328A
- Authority
- FI
- Finland
- Prior art keywords
- useful
- heterocyclic compounds
- muscarinic receptors
- allosteric effectors
- allosteric
- Prior art date
Links
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 title 1
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 title 1
- 239000012637 allosteric effector Substances 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9415175A GB9415175D0 (en) | 1994-07-27 | 1994-07-27 | Heterocyclic compounds, their preparation and their therapeutic use |
| GB9423948A GB9423948D0 (en) | 1994-11-25 | 1994-11-25 | Heterocyclic compounds, their preparation and their therapeutic use |
| PCT/JP1995/001494 WO1996003377A1 (en) | 1994-07-27 | 1995-07-27 | Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI970328A0 FI970328A0 (fi) | 1997-01-27 |
| FI970328A true FI970328A (fi) | 1997-03-27 |
Family
ID=26305347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI970328A FI970328A (fi) | 1994-07-27 | 1997-01-27 | Heterosykliset yhdisteet, jotka ovat käyttökelpoisia allosteerisinä effektoreina muskariinireseptoreissa |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5877199A (hu) |
| EP (1) | EP0804416A1 (hu) |
| KR (1) | KR970704687A (hu) |
| CN (1) | CN1166169A (hu) |
| AU (1) | AU686426B2 (hu) |
| CA (1) | CA2196046A1 (hu) |
| CZ (1) | CZ24197A3 (hu) |
| FI (1) | FI970328A (hu) |
| HU (1) | HUT76923A (hu) |
| MX (1) | MX9700696A (hu) |
| NO (1) | NO970308L (hu) |
| NZ (1) | NZ290199A (hu) |
| RU (1) | RU2152385C1 (hu) |
| WO (1) | WO1996003377A1 (hu) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100430059B1 (ko) * | 1995-04-10 | 2004-09-24 | 후지사와 야꾸힝 고교 가부시키가이샤 | cGMP-PDE억제제로서의인돌유도체 |
| AU4400597A (en) * | 1996-10-08 | 1998-05-05 | Fujisawa Pharmaceutical Co., Ltd. | Indole derivatives |
| US6548296B1 (en) | 1997-07-23 | 2003-04-15 | Roche Diagnostics Gmbh | Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof |
| GB9716657D0 (en) | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
| ZA989365B (en) * | 1997-10-15 | 1999-04-15 | Boehringer Mannheim Pharm Corp | Preparation for treating alzheimer's disease |
| GB9803226D0 (en) | 1998-02-17 | 1998-04-08 | Zeneca Ltd | Chemical compounds |
| CN1147299C (zh) * | 1998-02-23 | 2004-04-28 | 南亚拉巴马州医学科学基金会 | 吲哚-3-丙酸、其盐和酯制备药物的用途 |
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| GB9902455D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB9902452D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB9902453D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB9902461D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB9902459D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB9924962D0 (en) * | 1999-10-21 | 1999-12-22 | Mrc Collaborative Centre | Allosteric sites on muscarinic receptors |
| GB0000625D0 (en) | 2000-01-13 | 2000-03-01 | Zeneca Ltd | Chemical compounds |
| JP2004513076A (ja) | 2000-07-25 | 2004-04-30 | メルク エンド カムパニー インコーポレーテッド | 糖尿病治療で有用なｎ−置換インドール類 |
| ATE406371T1 (de) | 2000-11-02 | 2008-09-15 | Us Gov Health & Human Serv | Wirkstoffe für die verminderung von amyloid precursor protein und die behandlung von schwachsinn, und deren verfahren der verwendung |
| DE10164564B4 (de) * | 2001-12-14 | 2007-05-16 | Zentaris Gmbh | Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR) |
| WO2004037805A1 (en) | 2002-10-23 | 2004-05-06 | Glenmark Pharmaceuticals Ltd. | Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| DK1620429T3 (da) | 2003-04-11 | 2009-05-18 | Glenmark Pharmaceuticals Sa | Nye heterocykliske forbindelser anvendelige til behandling af inflammatoriske og allergiske sygdomme, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger indeholdende disse |
| EP1660450A4 (en) * | 2003-08-15 | 2009-07-29 | Univ Laval | MONOMERS, OLIGOMERS AND POLYMERS OF 2-FUNCTIONALIZED AND 2.7-DIFUNCTIONALIZED CARBAZOLES |
| US20060074124A1 (en) * | 2003-09-12 | 2006-04-06 | Andrew Napper | Methods of treating a disorder |
| US20050209300A1 (en) * | 2003-09-12 | 2005-09-22 | Andrew Napper | Methods of treating a disorder |
| ATE405549T1 (de) | 2004-06-18 | 2008-09-15 | Biolipox Ab | Zur behandlung von entzündungen geeignete indole |
| WO2006011024A2 (en) * | 2004-07-19 | 2006-02-02 | Glenmark Pharmaceuticals Ltd. | New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| WO2006046779A1 (ja) | 2004-10-29 | 2006-05-04 | Zeria Pharmaceutical Co., Ltd. | カルバゾール誘導体、その溶媒和物、又は薬学的に許容されるその塩 |
| MX2007007345A (es) | 2004-12-17 | 2007-09-07 | Glenmark Pharmaceuticals Sa | Compuestos heterociclicos novedosos utiles para el tratamiento de trastornos inflamatorios y alergicos. |
| SI1831227T1 (sl) | 2004-12-17 | 2013-09-30 | Glenmark Pharmaceuticals S.A. | Nove heterociklične spojine uporabne za zdravljenje vnetnih in alergijskih motenj |
| KR20070114123A (ko) | 2005-01-19 | 2007-11-29 | 바이올리폭스 에이비 | 염증 치료에 유용한 인돌 |
| GB2422828A (en) * | 2005-02-03 | 2006-08-09 | Hunter Fleming Ltd | Tricyclic cytoprotective compounds comprising an indole residue |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
| US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
| GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
| US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
| UA95788C2 (en) | 2005-12-15 | 2011-09-12 | Ф. Хоффманн-Ля Рош Аг | Fused pyrrole derivatives |
| EP2285803A4 (en) | 2008-05-23 | 2011-10-05 | Amira Pharmaceuticals Inc | Inhibitor of 5-Lipoxygenase Activating Protein |
| DK2669270T3 (en) * | 2011-01-28 | 2018-02-26 | Sato Pharma | Indole-related compounds such as URAT1 inhibitors |
| WO2013059245A1 (en) | 2011-10-17 | 2013-04-25 | Vanderbilt University | Indomethacin analogs for the treatment of castrate-resistant prostate cancer |
| CN103159934B (zh) * | 2011-12-13 | 2016-01-13 | 海洋王照明科技股份有限公司 | 含并噻唑单元的聚合物及其制备方法和太阳能电池器件 |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| EP2970177A1 (en) | 2013-03-15 | 2016-01-20 | Pfizer Inc. | Indole compounds that activate ampk |
| CN104530007A (zh) * | 2014-12-08 | 2015-04-22 | 湖南大学 | 一种单取代咔唑硫醚化合物的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1675478A (en) * | 1924-01-24 | 1928-07-03 | Grasselli Dyestuff Corp | Dyestuff intermediates |
| US3687969A (en) * | 1970-06-02 | 1972-08-29 | Sterling Drug Inc | 9-aroyl-1,2,3,4-tetrahydrocarbazole-3,3-dicarboxylic acids |
| DE2337154C2 (de) * | 1973-07-18 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue Carbazolderivate |
| US4178289A (en) * | 1978-06-26 | 1979-12-11 | Hoffmann-La Roche Inc. | Carbazole acetic acid derivatives |
| US4988820A (en) * | 1986-02-21 | 1991-01-29 | Bayer Aktiengesellschaft | Cycloalkano(1,2-B) indole-sulponamides |
| US5200419A (en) * | 1990-05-21 | 1993-04-06 | Warner-Lambert Company | Substituted tetrazoles and derivatives thereof acting at muscarinic receptors |
| TW239127B (hu) * | 1991-12-20 | 1995-01-21 | Hoffmann La Roche | |
| JPH06298732A (ja) * | 1993-02-16 | 1994-10-25 | Taisho Pharmaceut Co Ltd | インドール誘導体 |
-
1995
- 1995-07-27 NZ NZ290199A patent/NZ290199A/xx unknown
- 1995-07-27 EP EP95926509A patent/EP0804416A1/en not_active Withdrawn
- 1995-07-27 CN CN95195262A patent/CN1166169A/zh active Pending
- 1995-07-27 MX MX9700696A patent/MX9700696A/es unknown
- 1995-07-27 WO PCT/JP1995/001494 patent/WO1996003377A1/en not_active Application Discontinuation
- 1995-07-27 RU RU97102695/04A patent/RU2152385C1/ru active
- 1995-07-27 CA CA002196046A patent/CA2196046A1/en not_active Abandoned
- 1995-07-27 CZ CZ97241A patent/CZ24197A3/cs unknown
- 1995-07-27 AU AU30866/95A patent/AU686426B2/en not_active Ceased
- 1995-07-27 HU HU9700248A patent/HUT76923A/hu unknown
-
1997
- 1997-01-24 NO NO970308A patent/NO970308L/no unknown
- 1997-01-27 US US08/791,499 patent/US5877199A/en not_active Expired - Fee Related
- 1997-01-27 KR KR1019970700569A patent/KR970704687A/ko not_active Application Discontinuation
- 1997-01-27 FI FI970328A patent/FI970328A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3086695A (en) | 1996-02-22 |
| US5877199A (en) | 1999-03-02 |
| FI970328A0 (fi) | 1997-01-27 |
| NO970308L (no) | 1997-03-25 |
| KR970704687A (ko) | 1997-09-06 |
| WO1996003377A1 (en) | 1996-02-08 |
| NZ290199A (en) | 1999-06-29 |
| CN1166169A (zh) | 1997-11-26 |
| EP0804416A1 (en) | 1997-11-05 |
| NO970308D0 (no) | 1997-01-24 |
| HUT76923A (hu) | 1998-01-28 |
| CZ24197A3 (en) | 1997-08-13 |
| RU2152385C1 (ru) | 2000-07-10 |
| MX9700696A (es) | 1997-04-30 |
| CA2196046A1 (en) | 1996-02-08 |
| AU686426B2 (en) | 1998-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI970328A (fi) | Heterosykliset yhdisteet, jotka ovat käyttökelpoisia allosteerisinä effektoreina muskariinireseptoreissa | |
| NO20014412L (no) | Forbindelser nyttige som anti-inflammatoriske midler | |
| NO20013559L (no) | Aromatiske heterocykliske forbindelser som anti- inflammatoriske midler | |
| NO20004159L (no) | 2-pyridylmetylaminderivater for anvendelse som fungicider | |
| FI962800A (fi) | Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina | |
| IS5338A (is) | Ný spíróasabísýklísk heterósýklísk efnasambönd | |
| NO20004912L (no) | Forbindelser med innvirkning på muskarinreseptorer | |
| DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
| DK1102762T3 (da) | 2-substituerede-1-piperidylbenzimidazolforbindelser som ORL1-receptoragonister | |
| NO20005084L (no) | Heterosykliske glysyl <beta>-alanin derivater som vitronektinantagonister | |
| NO984106D0 (no) | Azolobenzazepin-derivater som neurologisk aktive midler | |
| NO971137D0 (no) | Dimetyl-(3-aryl-but-3-enyl)-aminforbindelse som farmasöytiske forbindelser | |
| NO20002036D0 (no) | Cyklopentenderivater nyttig som antagonister for motilinreseptoren | |
| NO971789D0 (no) | Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler | |
| NO20021251D0 (no) | Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister | |
| DK1086097T3 (da) | Sulfonylbenzenforbindelser som anti-inflammatoriske/analgetiske midler | |
| DK0799223T3 (da) | Piperidineddikesyrederivater til anvendelse som fibrinogenantagonistmidler | |
| NO994106L (no) | Oksazolidiner som 5-HT2A-antagonister | |
| DK1231211T3 (da) | Thiazolidindion-derivater som antidiabetika | |
| NO20012965D0 (no) | Sulfonyloksazolaminer som terapeutisk aktive forbindelser | |
| DK1075471T3 (da) | Idolylderivater som serotonerge midler | |
| NO993812L (no) | (4-piperidinyl)-1H-2benzopyranderivater som er anvendbare som antipsykotiske midler | |
| FI943359A0 (fi) | Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina | |
| NO20001751D0 (no) | Nye forbindelser til bruk som neuroprotektive midler | |
| DK0944601T3 (da) | Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister |